comparemela.com
Home
Live Updates
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer : comparemela.com
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
LA JOLLA, Calif., May 20, 2024 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange , today announced that it has...
Related Keywords
Tokyo ,
Japan ,
Kazuko Matsuda ,
Davidh Crean ,
Trademark Office ,
Nasdaq ,
Medicinova Inc ,
Uveal Melanoma In Molecular Cancer Research ,
Exchange Commission ,
Standard Market ,
Tokyo Stock Exchange ,
Code Number ,
Chief Medical Officer ,
Medicinova Announces New Data ,
Uveal Melanoma Presented ,
Medicinova Announces Publication ,
Uveal Melanoma ,
Molecular Cancer ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.